Production (Stage)
Core Scientific, Inc.
CORZ
$10.68
-$0.15-1.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 84.95M | 101.93M | 116.67M | 119.30M | 118.77M |
| Total Other Revenue | 325.96M | 408.74M | 441.01M | 455.93M | 442.27M |
| Total Revenue | 410.91M | 510.67M | 557.68M | 575.23M | 561.04M |
| Cost of Revenue | 347.04M | 377.37M | 394.14M | 400.95M | 391.71M |
| Gross Profit | 63.87M | 133.30M | 163.54M | 174.28M | 169.32M |
| SG&A Expenses | 157.64M | 134.44M | 119.69M | 101.90M | 95.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 12.82M | 1.59M | 4.71M | 4.82M | 3.90M |
| Total Operating Expenses | 527.53M | 523.44M | 525.43M | 513.98M | 496.46M |
| Operating Income | -116.62M | -12.77M | 32.24M | 61.25M | 64.58M |
| Income Before Tax | -944.15M | -1.31B | -1.24B | -830.24M | -34.62M |
| Income Tax Expenses | 858.00K | 859.00K | 820.00K | 800.00K | 785.00K |
| Earnings from Continuing Operations | -945.00 | -1.32K | -1.25K | -831.04 | -35.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -945.00M | -1.32B | -1.25B | -831.04M | -35.41M |
| EBIT | -116.62M | -12.77M | 32.24M | 61.25M | 64.58M |
| EBITDA | -12.68M | 100.44M | 150.61M | 175.16M | 169.49M |
| EPS Basic | -4.85 | -5.37 | -5.28 | -4.21 | 0.27 |
| Normalized Basic EPS | -3.19 | -4.07 | -3.65 | -2.70 | 0.13 |
| EPS Diluted | -5.04 | -5.51 | -5.42 | -4.36 | 0.13 |
| Normalized Diluted EPS | -3.34 | -4.12 | -3.70 | -2.75 | 0.08 |
| Average Basic Shares Outstanding | 1.09B | 1.01B | 1.09B | 1.18B | 1.37B |
| Average Diluted Shares Outstanding | 1.14B | 1.06B | 1.14B | 1.23B | 1.43B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |